Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 2/20 | 0.32 |
| ▸ | YWHAZ | P63104 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10148625 | 0.83 | NT5E (0.39) | L3MBTL1TMEM97SIGMAR1BCHE | |
| SCHEMBL15481393 | 0.81 | L3MBTL1 (0.39) | L3MBTL1SLC6A2MAPTCYP2C19MEN1 | |
| SCHEMBL402935 | 0.81 | PDPK1 (0.37) | L3MBTL1SLC6A2PDPK1MTORTMEM97 | |
| SCHEMBL7154934 | 0.81 | MEN1 (0.41) | L3MBTL1SLC6A2TMEM97SIGMAR1GSTP1 | |
| SCHEMBL12411312 | 0.81 | L3MBTL1 (0.36) | L3MBTL1SLC6A2MEN1KMT2AYWHAZ | |
| SCHEMBL11981185 | 0.79 | SLC6A2 (0.43) | L3MBTL1SLC6A2PDPK1MTORBCHE | |
| SCHEMBL8822994 | 0.79 | L3MBTL1 (0.50) | L3MBTL1PDPK1MTORTMEM97SIGMAR1 | |
| SCHEMBL6567769 | 0.79 | L3MBTL1 (0.39) | L3MBTL1SLC6A2TMEM97SIGMAR1GSTP1 | |
| SCHEMBL10831460 | 0.79 | L3MBTL1 (0.39) | L3MBTL1SLC6A2TMEM97SIGMAR1GSTP1 | |
| SCHEMBL16404640 | 0.78 | KMT2A (0.36) | L3MBTL1MAPTIDO1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114970-B2 | Synthetic heparin monosaccharides | ALCHEMIA LIMITED (AU) | 2012-02-14 | — | — | US | disclosed |
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA LIMITED (AU) | 2009-07-23 | — | — | US | disclosed |
| US-7541445-B2 | Synthetic heparin pentasaccharides | ALCHEMIA LIMITED (AU) | 2009-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090187013-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | HPSE, DDOST, STT3A | L3MBTL1 3682/4885SLC6A2 4439/4885PDPK1 4122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.